+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
Parkinson's Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Parkinson's Disease - Epidemiology Forecast - 2034

  • Report
  • October 2024
  • 159 Pages
  • Global
From
From
From
Chronic Heart Failure - Epidemiology Forecast - 2034 - Product Thumbnail Image

Chronic Heart Failure - Epidemiology Forecast - 2034

  • Report
  • October 2024
  • 165 Pages
  • Global
From
Myotonic Dystrophy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Myotonic Dystrophy - Epidemiology Forecast - 2034

  • Report
  • October 2024
  • 105 Pages
  • Global
From
Mild Cognitive Impairment - Epidemiology Forecast - 2034 - Product Thumbnail Image

Mild Cognitive Impairment - Epidemiology Forecast - 2034

  • Report
  • October 2024
  • 106 Pages
  • Global
From
From
From
From
From
From
From
Alzheimer's Disease (AD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Alzheimer's Disease (AD) - Epidemiology Forecast - 2034

  • Report
  • September 2024
  • 157 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more